ENSEM Therapeutics
Medford
About ENSEM Therapeutics
ENSEM Therapeutics is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small-molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $77.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2023)
- Website: ensemtx.com
- Phone: 781-874-2500
Industries & Categories
Biotechnology, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ensem-therapeutics-124415 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.